SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLASs sharp, high-volume decline without a disclosed company update has prompted debate over broader biotech weakness and options-expiration pressure versus company-specific concerns. Traders remain focused on the delayed 80th event and eventual Phase 3 REGAL readout, with bulls viewing the wait as potentially encouraging and bears questioning the trial and managements prolonged silence.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apples new foldable iPhone Duo reportedly sold through its initial preorder availability quickly, with delivery estimates pushed out, fueling optimism about demand. Traders debate whether the sellout reflects strong consumer interest or limited production, while also noting Apples relative resilience as other technology stocks face pressure.

Hyperliquid Strategies, Inc. is a holding and operating company, which engages in the business of crypto asset management. The firm operates as a digital asset treasury company which focuses on the Hyperliquid ecosystem. The company was founded on July 2, 2025 and is headquartered in New York, NY.

Hyperliquid Strategies Inc.

PURR is drawing attention amid a sharp pullback and debate over share dilution and selling pressure, even as traders track its exposure to Hyperliquids HYPE token. Bears see further downside from dilution and weak price action, while bulls argue that strength in HYPE could support a rebound in the treasury-focused stock.

Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.

Arcturus Therapeutics Holdings Inc

Arcturus Phase 2 update on its OTC-deficiency therapy, introduction of the LUNAR 2.0 delivery platform, and myNEO acquisition are driving discussion. Some traders view the data and platform expansion positively, while others question the delayed development timeline and added spending; separate outbreak-related vaccine speculation is also circulating.

Arm Holdings Plc engages in the licensing, marketing, research, and development of microprocessors, systems IP, graphics processing units, physical IP and associated systems IP, software, and tools. It operates through the following geographical segments: United Kingdom, United States, and Other Countries. The company was founded on November 12, 1990 and is headquartered in Cambridge, the United Kingdom.

Arm Holdings plc. - ADR

Arm Holdings Plc.

ARM is drawing attention amid a sharp pullback in semiconductor and AI-related stocks, with traders also questioning its rich valuation and the durability of AI spending. Some see the decline as a sector-wide reset and are buying the dip, while others expect further downside; no clear new company-specific catalyst dominates the discussion.

Barrick Mining Corp. engages in the production and sale of gold, copper, and related activities. It also provides exploration and mining development. It operates through the following business segments: Carlin, Cortez, Turquoise Ridge, Pueblo Viejo, Loulo-Gounkoto, Kibali, Veladero, North Mara, Bulyanhulu, and Other Mines. The company was founded by Peter D. Munk in 1983 and is headquartered in Toronto, Canada.

Barrick Mining Corp.

Barrick Mining Corp

Barrick is drawing attention amid weakness in gold and mining shares, with traders discussing whether a multi-swing correction could extend further. Some see hotter inflation and higher rate expectations as near-term headwinds for gold, while bullish traders remain focused on the longer-term precious-metals thesis and view pullbacks as opportunities.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeaves steep selloff is being tied to fears that its debt-funded AI data-center expansion could become harder to finance, alongside weakness in AI and semiconductor stocks; reports of substantial insider selling have added to the pressure. Traders are split between concerns about refinancing and default risk and dip-buying optimism based on AI demand, a large backlog, and Nvidias support.

Robinhood GLD is a tokenized representation of SPDR Gold Shares (GLD) common stock, issued on Robinhood Chain, Robinhood's own blockchain built to bring tokenized real-world assets on-chain. Each token is designed to track the price of the underlying GLD share, giving holders on-chain price exposure to SPDR Gold Shares's stock. The token is freely transferable and composable across the Robinhood Chain ecosystem. It's part of Robinhood's broader initiative to expand access to tokenized U.S. equities via blockchain technology, alongside a wider lineup of tokenized stock tokens launching on the same network.

GoldCoin

Golds pullback is the dominant focus, with traders linking pressure on bullion to rising Treasury yields, a stronger dollar, and expectations of further Fed rate hikes after hot inflation data. Some see the weakness as a buying opportunity and continue to favor gold as a hedge, while others expect more downside as yields and the dollar remain firm.

Hut 8 Corp. engages in the development and operation of data centers at scale, supporting AI, high-performance computing (HPC), ASIC compute, and other energy-intensive technology applications. It operates through the following segments: Power, Digital Infrastructure, Compute, and Others. The Power segment manages the origination, development, and management of powered land and energy infrastructure. The Digital Infrastructure refers to the development, ownership, and operation of facilities designed to support next-generation, energy-intensive technology application. The Compute segment deals with operating businesses that deploy and monetize compute assets across next-generation energy-intensive technology. The Others segment offers equipment sales and repairs. The company was founded on January 27, 2023 and is headquartered in Miami, FL.

Hut 8 Corp

HUT is caught in a broad selloff across Bitcoin miners expanding into AI and data-center infrastructure, as traders point to rising yields and worries about project financing and execution; Cantor Fitzgeralds reduced price target has added to the discussion despite its continued bullish rating. The community is split between calling the drop an overreaction and expecting further declines.

Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It operates through the following segments: Commercial Product Sales, MCM Product Sales, and Services. The Commercial Product Sales segment includes NARCAN products and other commercial products that were sold as part of the travel health business. The MCM Product Sales segment focuses on the Anthrax - MCM products, Smallpox - MCM products and other products. The Services segment consists of the company’s Bioservices offerings. It offers products for civilian and military populations that address accidental, intentional, and naturally occurring public health threats. The company was founded by Fuad El-Hibri on September 5, 1998 and is headquartered in Gaithersburg, MD.

Emergent Biosolutions Inc

Emergents announced CFO retirement and planned handoff to its treasurer as interim CFO are prompting concern amid the share decline. Some traders speculate the transition signals accounting or financial trouble, while others view it as a routine, planned succession and consider the reaction excessive.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$CKPT For everyone asking about updates. The best place to get updates is from Sun Pharma. Unfortunately, they aren&#39;t traded in the US, so no SEC filings. But you can view their press releases here: https://sunpharma.com/media/ 
 
The big thing to pay attention to is when they announce positive validation of the MAA for UNLOXCYT. That starts the clock. To get the $0.70 payout, UNLOXCYT needs to be approved within 2 years of positive MAA validation at an approved dose of once very 3 weeks (see chart). 
 
Per the agreement, Sun has to submit UNLOXCYT&#39;s  MAA in Europe by May 30, 2026. After it is submitted, they have to wait for it to be validated before the EMA starts the approval process.

meat_suit

Lenni

Francisc Bozga

yacag123

Here you will find our latest & archived press releases and our corporate brand guidelines.

Sun Pharmaceutical Industries Ltd.

Media | Press Releases - Sun Pharmaceutical

StockTwits Web

Checkpoint Therapeutics Inc

 For everyone asking about updates. The best place to get updates is from Sun Pharma. Unfortunately, they aren't traded in the US, so no SEC filings. But you can view their press releases here: 

 
 
The big thing to pay attention to is when they announce positive validation of the MAA for UNLOXCYT. That starts the clock. To get the $0.70 payout, UNLOXCYT needs to be approved within 2 years of positive MAA validation at an approved dose of once very 3 weeks (see chart). 
 
Per the agreement, Sun has to submit UNLOXCYT's  MAA in Europe by May 30, 2026. After it is submitted, they have to wait for it to be validated before the EMA starts the approval process.